Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 409
Selected: 0
NCT IDTitle
NCT03487900Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up
NCT019354928 Continuous vs 8 Intermittent Cycles in First and Second Line in HER2/Neu Neg Metastatic Breast Cancer
NCT01205854Aiming for Remission in Rheumatoid Arthritis (RA) - the ARCTIC Trial
NCT02049853The Triple A Initiative Study ("Aktionsbündnis Akute Atemnot")
NCT04702256Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
NCT05008081The CATALINA Study
NCT00769522FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
NCT00333437Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement
NCT00730769Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients
NCT00201734Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
NCT00562952Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients
NCT02758665Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL
NCT02987400Combination of Obinutuzumab and Venetoclax in Relapsed or Refractory DLBCL
NCT00226798Immunochemotherapy for Metastatic Renal Cell Carcinoma
NCT01326559Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)
NCT05825625NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing
NCT01661790Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
NCT03892525Study of Intratumoral Selicrelumab With Atezolizumab in Patients With Refractory or Relapsed B Cell Lymphoma
NCT04462276Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease
NCT02814487MSFC Versus DAM. A Smartphone Application for Multiple Sclerosis Self-assessment.
NCT00411762A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
NCT02344472Detect V / CHEVENDO (Chemo vs. Endo)
NCT03767075A Modular Multi-Basket Trial to Improve Personalized Medicine in Cancer Patients (Basket of Baskets)
NCT01752192Teledi@Log - Tele-rehabilitation of Heart Patients
NCT00100659PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C
NCT01076023Cohort Study in Type 2 Diabetes in China
NCT00227370Comparison of Oral Valganciclovir and Placebo for the Prevention of Cytomegalovirus (CMV) After Lung Transplantation
NCT02622581Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
NCT01633346Regulation of the Immune System in Response to the Treatment With Tocilizumab in Rheumatoid Arthritis Patients
NCT01016639Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer
NCT04661358Fenofibrate for Prevention of DR Worsening
NCT00352092Pilot Study for HLA Identical Living Donor Renal Transplant Recipients
NCT01306409Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)
NCT00273767Preliminary Administration of EPO and Markers of Cardiac Ischemia Induced by CPB
NCT00719264Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer
NCT00509184Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma
NCT01817452A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Combination of Trastuzumab and Pertuzumab With or Without Concurrent Taxane Chemotherapy Given for Twelve Weeks in Patients With Operable HER2+/HR- Breast Cancer Within the ADAPT Protocol
NCT02894853Lung Cancer Early Molecular Assessment Trial
NCT03820063Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study
NCT01370772Intensified Rituimab Prephase Before FCR in Untreated B-CLL
NCT04445272Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia
NCT01640444Influence of BRAF and PIK3K Status on the Efficacy of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFIRI) Plus Bevacizumab or Cetuximab in Patients With RAS Wild-type Metastatic Colorectal Carcinoma and < 3 Circulating Tumor Cells (CTC)
NCT03519295A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma
NCT00293072Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis
NCT02636452Cardiopulmonary Exercise Testing in Interstitial Lung Disease
NCT01714908Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21
NCT04470947Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies
NCT02383290The Implementation of Pharmacogenomics Into Primary Care in British Columbia
NCT00774462Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
NCT00216086Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer